Medicine Description retarpen 1.200000i
Retarpen 1.200000i Vial is a medication that contains Benzathine Penicillin G, a long-acting form of penicillin. Its mechanism of action involves inhibiting bacterial cell wall synthesis. By binding to penicillin-binding proteins (PBPs) located within the bacterial cell wall, Benzathine Penicillin G disrupts the transpeptidation process, which is essential for the cross-linking of peptidoglycan layers. This ultimately results in bacterial cell lysis and death. Due to its prolonged release from the injection site, Retarpen maintains therapeutic levels in the bloodstream for an extended period, making it effective for treating various infections, particularly those caused by susceptible strains of bacteria, such as Streptococcus pyogenes.
Indications and Uses of Retarpen 1.200000i Vial
- Prophylaxis of rheumatic fever
- Treatment of syphilis
- Management of streptococcal infections
- Prevention of infections in patients with a history of rheumatic heart disease
Side Effects of Retarpen 1.200000i Vial
- Allergic reactions, including rash and anaphylaxis
- Nausea and vomiting
- Diarrhea
- Local injection site reactions, such as pain or swelling
- Rarely, hematologic reactions such as hemolytic anemia
Storage and Handling
Store Retarpen 1.200000i Vial at room temperature, away from light and moisture. It should be kept out of reach of children and not frozen.
Patient Advice and Precautions
It is important to complete the full course of treatment as prescribed, even if symptoms improve before finishing the medication. Patients should be monitored for signs of allergic reactions, particularly after the first dose. Inform healthcare providers about any history of allergies to penicillin or other antibiotics. Patients with a history of rheumatic fever should have regular follow-up appointments to monitor for recurrent episodes.